Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
Add My Products
Innova Introduces Lightning-Link Rapid Bioconjugation Kits
Tuesday, November 04, 2014
New kits enable customers to conjugate primary antibodies in 20 minutes.
Improved Method for Protein Quality Control
Friday, October 31, 2014
Separation of intact monoclonal antibody sialylation isoforms by pH gradient ion-exchange chromatography.
Randox Launches World’s Most Comprehensive Third Party Haematology Control
Wednesday, October 29, 2014
Randox Laboratories has launched a third party multi-analyte haematology control; the most comprehensive haematology quality control (QC) solution on the market to date.
Bulldog Bio Provides Novel Adjuvant Enhancer for Improved Vaccinations
Tuesday, October 28, 2014
New Opticcine Adjuvant Enhancer improves immune response against a wide variety of antigens.
PerkinElmer Launches Mantra™ Quantitative Pathology Imaging System
Tuesday, October 28, 2014
New imaging system enables researchers to visualize, quantify, analyze and phenotype multiple types of immune cells simultaneously in solid tumors.
Blood-Derived Products for Personalized Medicine Research
Tuesday, October 21, 2014
Blood-derived products includes whole blood, serum, plasma, buffy coat and peripheral blood mononuclear cells.
TxCell to Present on T Cellular Therapy for Autoimmune Diseases
Thursday, October 16, 2014
Dr. Miguel Forte will present at the 7th National Bio-Therapy Conference 2014, China.
Gyros Launches Gyrolab Protein A Kit for Efficient Quantification of Residual Protein A
Wednesday, October 08, 2014
Optimized kit for use with Gyros immunoassay platform.
Novosanis and University of Antwerp Receive Prestigious James Dyson Award
Tuesday, September 23, 2014
Company receives award as a national winner for its VAX-ID device.
Showing Results 31 - 40 of 393
Sorting Through Cellular Statistics
Aaron Dinner, professor in chemistry, and his graduate student Herman Gudjonson are trying to read the manual of life, DNA, as part of the Dinner group’s research into bioinformatics—the application of statistics to biological research.
Women’s Immune System Genes Operate Differently from Men’s
A new technology reveals that immune system genes switch on and off differently in women and men, and the source of that variation is not primarily in the DNA.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Immune System 'On Switch' Breakthrough Could Lead to Targeted Drugs
A crucial 'on switch' that boosts the body's defenses against infections has been successfully identified in new scientific research.
Advertise On This Site
Terms & Conditions
©2015 Technology Networks
, all rights reserved.
Latest presentations and webinars
2,400+ scientific and medical posters
3,700+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FREE!